Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04131725 · ClinicalTrials.gov registry record
Cardiac Function Non-Invasive Monitoring System Evaluation Trial
A clinical trial, sponsored by Sensydia Corporation.
- Completed
- Registry status
- 275
- Enrollment target
NCT04131725 is a clinical trial that has completed, run by Sensydia Corporation. The registered enrollment target is 275 participants.
The verdict
NCT04131725 has completed, sponsored by Sensydia Corporation.
- COMPLETED
- Registry status
- 275 participants
- Enrollment target
Study Summary
Non-significant risk device study to conduct evaluation of the performance of new device for monitoring of cardiac function (based on previous iterations 510(k) 173156)
Interventions
- DEVICE Cardiac Performance System (NSR)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 275 participants |
| Start Date | 2020-11-09 |
| Est. Completion | 2023-04-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04131725
The ClinicalTrials.gov registry entry for NCT04131725 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 275 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Sensydia Corporation, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Cardiac Performance System (NSR) is the first listed.
NCT04131725 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04131725 about?
NCT04131725 is a clinical study titled "Cardiac Function Non-Invasive Monitoring System Evaluation Trial". Non-significant risk device study to conduct evaluation of the performance of new device for monitoring of cardiac function (based on previous iterations 510(k) 173156)
What is the current status of trial NCT04131725?
This trial is currently completed. The enrollment target is 275 participants. The study started on 2020-11-09. Estimated completion is 2023-04-30.
What interventions are being tested in trial NCT04131725?
The interventions under investigation include: Cardiac Performance System (NSR) (DEVICE).
Who is sponsoring clinical trial NCT04131725?
This trial is sponsored by Sensydia Corporation, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.